Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

Private equity firms TPG and Blackstone (NYSE:BX) recently bid to acquire Hologic Inc. (NASDAQ:HOLX), valuing the U.S. medical technology company at over $16 billion.Hologic is an American medical technology company primarily focused on women’s health. It sells medical devices for diagnostics, surgery, and imaging.While Hologic rejected the initial nonbinding offer, citing sources, the Financial Times writes that the negotiations could resume.Benzinga reached out to Hologic for comments.Also Read: FDA Warns Hologic Over BioZorb Manufacturing ViolationsThe proposed buyout valued Hologic between $16.3 billion and $16.7 billion, including debt, and would have priced shares at $70 to $72—well above the company’s closing price of $54.28 on Friday.The FT report ...Full story available on Benzinga.comWeiter zum vollständigen Artikel bei Benzinga Weiter zum vollständigen Artikel bei Benzinga